Stay updated on Sepofarsen Repeat-dose in LCA10 Clinical Trial

Sign up to get notified when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sepofarsen Repeat-dose in LCA10 Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov record for the sepofarsen study appears unchanged.
    Difference
    0.1%
    Check dated 2026-11-14T14:17:56.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The record now presents details of the sepofarsen (QR-110) LCA10 study, including its design, eligibility criteria, locations, and outcome measures, instead of a Forbidden error page.
    Difference
    67%
    Check dated 2026-11-07T14:06:18.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:49:48.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-24T15:24:36.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T15:12:58.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:21:00.000Z thumbnail image

Stay in the know with updates to Sepofarsen Repeat-dose in LCA10 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.